Wells Fargo’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-74,225
| Closed | -$18.2M | – | 7868 |
|
|
2022
Q3 | $18.2M | Sell |
74,225
-9,559
| -11% | -$2.58M | 0.01% | 1120 |
|
|
2022
Q2 | $20.7M | Sell |
83,784
-35,424
| -30% | -$9.56M | 0.01% | 1117 |
|
|
2022
Q1 | $39.5M | Buy |
119,208
+18,860
| +19% | +$5.81M | 0.01% | 896 |
|
|
2021
Q4 | $36M | Sell |
100,348
-231,454
| -70% | -$78.2M | 0.01% | 950 |
|
|
2021
Q3 | $108M | Sell |
331,802
-19,649
| -6% | -$6.66M | 0.02% | 620 |
|
|
2021
Q2 | $110M | Sell |
351,451
-94,680
| -21% | -$29M | 0.02% | 632 |
|
|
2021
Q1 | $142M | Sell |
446,131
-4,604
| -1% | -$1.47M | 0.03% | 510 |
|
|
2020
Q4 | $146M | Buy |
450,735
+73,601
| +20% | +$20.4M | 0.04% | 483 |
|
|
2020
Q3 | $104M | Buy |
377,134
+71,308
| +23% | +$20.5M | 0.03% | 549 |
|
|
2020
Q2 | $73.9M | Buy |
305,826
+239,151
| +359% | +$48M | 0.02% | 672 |
|
|
2020
Q1 | $9.68M | Buy |
66,675
+10,581
| +19% | +$1.76M | ﹤0.01% | 1690 |
|
|
2019
Q4 | $9.57M | Sell |
56,094
-12,390
| -18% | -$2.3M | ﹤0.01% | 1994 |
|
|
2019
Q3 | $12.2M | Sell |
68,484
-192,154
| -74% | -$41.5M | ﹤0.01% | 1804 |
|
|
2019
Q2 | $67.9M | Buy |
260,638
+147,761
| +131% | +$39.2M | 0.02% | 771 |
|
|
2019
Q1 | $32.2M | Buy |
112,877
+4,028
| +4% | +$1.34M | 0.01% | 1149 |
|
|
2018
Q4 | $35.4M | Sell |
108,849
-33,767
| -24% | -$11.7M | 0.01% | 1020 |
|
|
2018
Q3 | $64.1M | Buy |
142,616
+8,074
| +6% | +$3.18M | 0.02% | 798 |
|
|
2018
Q2 | $55M | Buy |
134,542
+52,986
| +65% | +$19.2M | 0.02% | 864 |
|
|
2018
Q1 | $23.7M | Sell |
81,556
-163,685
| -67% | -$41.5M | 0.01% | 1352 |
|
|
2017
Q4 | $46M | Sell |
245,241
-119,186
| -33% | -$22.3M | 0.01% | 936 |
|
|
2017
Q3 | $61.4M | Buy |
364,427
+348,715
| +2,219% | +$52.7M | 0.02% | 769 |
|
|
2017
Q2 | $2.25M | Buy |
15,712
+1,297
| +9% | +$174K | ﹤0.01% | 3126 |
|
|
2017
Q1 | $1.81M | Sell |
14,415
-48,049
| -77% | -$5.57M | ﹤0.01% | 3287 |
|
|
2016
Q4 | $7.04M | Sell |
62,464
-50,490
| -45% | -$5.85M | ﹤0.01% | 2123 |
|
|
2016
Q3 | $14.5M | Sell |
112,954
-73,605
| -39% | -$8.82M | 0.01% | 1510 |
|
|
2016
Q2 | $20.4M | Sell |
186,559
-19,894
| -10% | -$1.98M | 0.01% | 1293 |
|
|
2016
Q1 | $19.6M | Buy |
206,453
+26,570
| +15% | +$2.24M | 0.01% | 1288 |
|
|
2015
Q4 | $16.2M | Buy |
179,883
+143,624
| +396% | +$12.2M | 0.01% | 1461 |
|
|
2015
Q3 | $3.36M | Sell |
36,259
-505
| -1% | -$44.5K | ﹤0.01% | 2603 |
|
|
2015
Q2 | $2.42M | Buy |
36,764
+32,863
| +842% | +$2.18M | ﹤0.01% | 2956 |
|
|
2015
Q1 | $279K | Buy |
3,901
+1,231
| +46% | +$66.8K | ﹤0.01% | 4254 |
|
|
2014
Q4 | $101K | Sell |
2,670
-480
| -15% | -$15.1K | ﹤0.01% | 4736 |
|
|
2014
Q3 | $78K | Sell |
3,150
-485
| -13% | -$12.3K | ﹤0.01% | 4756 |
|
|
2014
Q2 | $91K | Buy |
3,635
+2,841
| +358% | +$66.1K | ﹤0.01% | 4722 |
|
|
2014
Q1 | $21K | Buy |
794
+293
| +58% | +$8.11K | ﹤0.01% | 5213 |
|
|
2013
Q4 | $13K | Hold |
501
| – | – | ﹤0.01% | 5131 |
|
|
2013
Q3 | $10K | Hold |
501
| – | – | ﹤0.01% | 5124 |
|
|
2013
Q2 | $11K | Buy |
+501
| New | +$10.1K | ﹤0.01% | 5042 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Wells Fargo's ABMD Position: Q4 2022 in Review
Wells Fargo sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 74,225 shares — an estimated $18.2M sold.
Wells Fargo first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $146M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Wells Fargo reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Wells Fargo sold 74,225 Abiomed Inc shares in Q4 2022, an estimated $18.2M.
- Wells Fargo first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
- Wells Fargo's Abiomed Inc position peaked at $146M in Q4 2020.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.